The global Bacteriophage Therapy market size was valued at US$ 31 million in 2023. With growing demand in downstream market, the Bacteriophage Therapy is forecast to a readjusted size of US$ 61 million by 2030 with a CAGR of 10.0% during review period.
The research report highlights the growth potential of the global Bacteriophage Therapy market. Bacteriophage Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Bacteriophage Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Bacteriophage Therapy market.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Bacteriophage Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Bacteriophage Therapy market. It may include historical data, market segmentation by Type (e.g., Oral, Topical), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Bacteriophage Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Bacteriophage Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Bacteriophage Therapy industry. This include advancements in Bacteriophage Therapy technology, Bacteriophage Therapy new entrants, Bacteriophage Therapy new investment, and other innovations that are shaping the future of Bacteriophage Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Bacteriophage Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Bacteriophage Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Bacteriophage Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Bacteriophage Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Bacteriophage Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Bacteriophage Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Bacteriophage Therapy market.
Market Segmentation:
Bacteriophage Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Oral
Topical
Parenteral
Segmentation by application
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Armata Pharmaceuticals, Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix, Inc.
Phagelux Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro, Inc.
Adaptive Phage Therapeutics, Inc.
EnBiotix, Inc.
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bacteriophage Therapy Market Size 2019-2030
2.1.2 Bacteriophage Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Bacteriophage Therapy Segment by Type
2.2.1 Oral
2.2.2 Topical
2.2.3 Parenteral
2.3 Bacteriophage Therapy Market Size by Type
2.3.1 Bacteriophage Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Bacteriophage Therapy Market Size Market Share by Type (2019-2024)
2.4 Bacteriophage Therapy Segment by Application
2.4.1 Organ Transplantation
2.4.2 Bacterial Infections
2.4.3 Alcoholic Hepatitis
2.4.4 Other
2.5 Bacteriophage Therapy Market Size by Application
2.5.1 Bacteriophage Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Bacteriophage Therapy Market Size Market Share by Application (2019-2024)
3 Bacteriophage Therapy Market Size by Player
3.1 Bacteriophage Therapy Market Size Market Share by Players
3.1.1 Global Bacteriophage Therapy Revenue by Players (2019-2024)
3.1.2 Global Bacteriophage Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Bacteriophage Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bacteriophage Therapy by Regions
4.1 Bacteriophage Therapy Market Size by Regions (2019-2024)
4.2 Americas Bacteriophage Therapy Market Size Growth (2019-2024)
4.3 APAC Bacteriophage Therapy Market Size Growth (2019-2024)
4.4 Europe Bacteriophage Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Bacteriophage Therapy Market Size Growth (2019-2024)
5 Americas
5.1 Americas Bacteriophage Therapy Market Size by Country (2019-2024)
5.2 Americas Bacteriophage Therapy Market Size by Type (2019-2024)
5.3 Americas Bacteriophage Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bacteriophage Therapy Market Size by Region (2019-2024)
6.2 APAC Bacteriophage Therapy Market Size by Type (2019-2024)
6.3 APAC Bacteriophage Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bacteriophage Therapy by Country (2019-2024)
7.2 Europe Bacteriophage Therapy Market Size by Type (2019-2024)
7.3 Europe Bacteriophage Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bacteriophage Therapy by Region (2019-2024)
8.2 Middle East & Africa Bacteriophage Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Bacteriophage Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Bacteriophage Therapy Market Forecast
10.1 Global Bacteriophage Therapy Forecast by Regions (2025-2030)
10.1.1 Global Bacteriophage Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Bacteriophage Therapy Forecast
10.1.3 APAC Bacteriophage Therapy Forecast
10.1.4 Europe Bacteriophage Therapy Forecast
10.1.5 Middle East & Africa Bacteriophage Therapy Forecast
10.2 Americas Bacteriophage Therapy Forecast by Country (2025-2030)
10.2.1 United States Bacteriophage Therapy Market Forecast
10.2.2 Canada Bacteriophage Therapy Market Forecast
10.2.3 Mexico Bacteriophage Therapy Market Forecast
10.2.4 Brazil Bacteriophage Therapy Market Forecast
10.3 APAC Bacteriophage Therapy Forecast by Region (2025-2030)
10.3.1 China Bacteriophage Therapy Market Forecast
10.3.2 Japan Bacteriophage Therapy Market Forecast
10.3.3 Korea Bacteriophage Therapy Market Forecast
10.3.4 Southeast Asia Bacteriophage Therapy Market Forecast
10.3.5 India Bacteriophage Therapy Market Forecast
10.3.6 Australia Bacteriophage Therapy Market Forecast
10.4 Europe Bacteriophage Therapy Forecast by Country (2025-2030)
10.4.1 Germany Bacteriophage Therapy Market Forecast
10.4.2 France Bacteriophage Therapy Market Forecast
10.4.3 UK Bacteriophage Therapy Market Forecast
10.4.4 Italy Bacteriophage Therapy Market Forecast
10.4.5 Russia Bacteriophage Therapy Market Forecast
10.5 Middle East & Africa Bacteriophage Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Bacteriophage Therapy Market Forecast
10.5.2 South Africa Bacteriophage Therapy Market Forecast
10.5.3 Israel Bacteriophage Therapy Market Forecast
10.5.4 Turkey Bacteriophage Therapy Market Forecast
10.5.5 GCC Countries Bacteriophage Therapy Market Forecast
10.6 Global Bacteriophage Therapy Forecast by Type (2025-2030)
10.7 Global Bacteriophage Therapy Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Armata Pharmaceuticals, Inc.
11.1.1 Armata Pharmaceuticals, Inc. Company Information
11.1.2 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Offered
11.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Armata Pharmaceuticals, Inc. Main Business Overview
11.1.5 Armata Pharmaceuticals, Inc. Latest Developments
11.2 Eliava Biopreparations Ltd.
11.2.1 Eliava Biopreparations Ltd. Company Information
11.2.2 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Offered
11.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Eliava Biopreparations Ltd. Main Business Overview
11.2.5 Eliava Biopreparations Ltd. Latest Developments
11.3 Pherecydes Pharma
11.3.1 Pherecydes Pharma Company Information
11.3.2 Pherecydes Pharma Bacteriophage Therapy Product Offered
11.3.3 Pherecydes Pharma Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pherecydes Pharma Main Business Overview
11.3.5 Pherecydes Pharma Latest Developments
11.4 Intralytix, Inc.
11.4.1 Intralytix, Inc. Company Information
11.4.2 Intralytix, Inc. Bacteriophage Therapy Product Offered
11.4.3 Intralytix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Intralytix, Inc. Main Business Overview
11.4.5 Intralytix, Inc. Latest Developments
11.5 Phagelux Inc.
11.5.1 Phagelux Inc. Company Information
11.5.2 Phagelux Inc. Bacteriophage Therapy Product Offered
11.5.3 Phagelux Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Phagelux Inc. Main Business Overview
11.5.5 Phagelux Inc. Latest Developments
11.6 Nextbiotics
11.6.1 Nextbiotics Company Information
11.6.2 Nextbiotics Bacteriophage Therapy Product Offered
11.6.3 Nextbiotics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Nextbiotics Main Business Overview
11.6.5 Nextbiotics Latest Developments
11.7 InnoPhage, Ltd
11.7.1 InnoPhage, Ltd Company Information
11.7.2 InnoPhage, Ltd Bacteriophage Therapy Product Offered
11.7.3 InnoPhage, Ltd Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 InnoPhage, Ltd Main Business Overview
11.7.5 InnoPhage, Ltd Latest Developments
11.8 Locus Biosciences, Inc.
11.8.1 Locus Biosciences, Inc. Company Information
11.8.2 Locus Biosciences, Inc. Bacteriophage Therapy Product Offered
11.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Locus Biosciences, Inc. Main Business Overview
11.8.5 Locus Biosciences, Inc. Latest Developments
11.9 TechnoPhage
11.9.1 TechnoPhage Company Information
11.9.2 TechnoPhage Bacteriophage Therapy Product Offered
11.9.3 TechnoPhage Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 TechnoPhage Main Business Overview
11.9.5 TechnoPhage Latest Developments
11.10 Eligo Bioscience SA
11.10.1 Eligo Bioscience SA Company Information
11.10.2 Eligo Bioscience SA Bacteriophage Therapy Product Offered
11.10.3 Eligo Bioscience SA Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Eligo Bioscience SA Main Business Overview
11.10.5 Eligo Bioscience SA Latest Developments
11.11 Phagomed Biopharma GmbH.
11.11.1 Phagomed Biopharma GmbH. Company Information
11.11.2 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Offered
11.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Phagomed Biopharma GmbH. Main Business Overview
11.11.5 Phagomed Biopharma GmbH. Latest Developments
11.12 PhagePro, Inc.
11.12.1 PhagePro, Inc. Company Information
11.12.2 PhagePro, Inc. Bacteriophage Therapy Product Offered
11.12.3 PhagePro, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 PhagePro, Inc. Main Business Overview
11.12.5 PhagePro, Inc. Latest Developments
11.13 Adaptive Phage Therapeutics, Inc.
11.13.1 Adaptive Phage Therapeutics, Inc. Company Information
11.13.2 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Offered
11.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Adaptive Phage Therapeutics, Inc. Main Business Overview
11.13.5 Adaptive Phage Therapeutics, Inc. Latest Developments
11.14 EnBiotix, Inc.
11.14.1 EnBiotix, Inc. Company Information
11.14.2 EnBiotix, Inc. Bacteriophage Therapy Product Offered
11.14.3 EnBiotix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 EnBiotix, Inc. Main Business Overview
11.14.5 EnBiotix, Inc. Latest Developments
11.15 Intodeworld, Inc.
11.15.1 Intodeworld, Inc. Company Information
11.15.2 Intodeworld, Inc. Bacteriophage Therapy Product Offered
11.15.3 Intodeworld, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Intodeworld, Inc. Main Business Overview
11.15.5 Intodeworld, Inc. Latest Developments
11.16 BiomX Ltd.
11.16.1 BiomX Ltd. Company Information
11.16.2 BiomX Ltd. Bacteriophage Therapy Product Offered
11.16.3 BiomX Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 BiomX Ltd. Main Business Overview
11.16.5 BiomX Ltd. Latest Developments
11.17 Phi Therapeutics
11.17.1 Phi Therapeutics Company Information
11.17.2 Phi Therapeutics Bacteriophage Therapy Product Offered
11.17.3 Phi Therapeutics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Phi Therapeutics Main Business Overview
11.17.5 Phi Therapeutics Latest Developments
11.18 Fixed-phage Ltd.
11.18.1 Fixed-phage Ltd. Company Information
11.18.2 Fixed-phage Ltd. Bacteriophage Therapy Product Offered
11.18.3 Fixed-phage Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Fixed-phage Ltd. Main Business Overview
11.18.5 Fixed-phage Ltd. Latest Developments
11.19 Micreos BV
11.19.1 Micreos BV Company Information
11.19.2 Micreos BV Bacteriophage Therapy Product Offered
11.19.3 Micreos BV Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Micreos BV Main Business Overview
11.19.5 Micreos BV Latest Developments
11.20 ContraFect Corporation
11.20.1 ContraFect Corporation Company Information
11.20.2 ContraFect Corporation Bacteriophage Therapy Product Offered
11.20.3 ContraFect Corporation Bacteriophage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 ContraFect Corporation Main Business Overview
11.20.5 ContraFect Corporation Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
